TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
PCVX

Vaxcyte Inc

Healthcare · Biotechnology

60.40$ +2.7% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Vaxcyte Inc (PCVX): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/03/2026.

Next report 11/03/2026
Last report 08/05/2026
Earnings surprise by quarter (%)
Q3 23 · -8.3 % 23 Q4 23 · -70.1 % 23 Q1 24 · 19.8 % 24 Q2 24 · -10.0 % 24 Q3 24 · 16.2 % 24 Q4 24 · -2.6 % 24 Q1 25 · -7.2 % 25 Q2 25 · -5.2 % 25 Q3 25 · -25.8 % 25 Q4 25 · -22.5 % 25 Q1 26 · -29.9 % 26 Q2 26 · -34.0 % 26

EPS estimate beaten

Full history 11 of 27 quarters (41%)
Last 16 quarters 4 of 16 quarters (25%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/03/2026 Vaxcyte, Inc. (PCVX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/05/2026 Vaxcyte, Inc. (PCVX): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/15/2026 Vaxcyte, Inc. (PCVX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?